Status:
COMPLETED
A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Autoimmune Bullous Disease
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The purpose of this study is to identify the presence or absence of ectopic lymph node-like structures in skin lesions of patients with autoimmune bullous disease and the subtypes of the cells deposit...
Eligibility Criteria
Inclusion
- \<Presence of Ectopic Lymphoid-like Structures in the Skin lesion of Autoimmune Bullous Disease Patients\>
- Prospective study
- Adults over 19
- Patietns who voluntarily signed the consent form
- Patients who are diagnosed with autoimmune bullous disease through clinical, histological and serological tests
- Retrospective study
- Samples in human-derived banks from March 2013 to October 2018
- Patients who are diagnosed with autoimmune bullous disease through clinical, histological and serological tests
- Adults over 19 \<Treatment of Ectopic Lymphoid-like Structures in the Skin lesion of Autoimmune Bullous Disease Patients\>
- Prospective study
- Adults over 19
- Patients who voluntarily signed the consent form
- Patients who have skin lesions harboring ectopic lymph node-like structure in a prospective or retrospective manner
- Patients who have chronic lesions sustained for more than 4 months during the treatment of systemic corticosteroids
- Retrospective study
- Patients who have skin lesions harboring ectopic lymph node-like structure in a retrospective manner
- Paitents who have been treated for intralesional steroid injection
- Patients who have data of photography to compare the clinical effects before and after intralesional corticosteroid treatment.
Exclusion
- 1\. Patients who do not meet the criteria for autoimmune bullous disease
Key Trial Info
Start Date :
February 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04509570
Start Date
February 8 2019
End Date
October 31 2022
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GangnamSeverance Hospital
Seoul, South Korea